O

Oscotec Inc
KOSDAQ:039200

Watchlist Manager
Oscotec Inc
KOSDAQ:039200
Watchlist
Price: 43 300 KRW -4.2% Market Closed
Market Cap: 1.7T KRW

Relative Value

The Relative Value of one Oscotec Inc stock under the Base Case scenario is hidden KRW. Compared to the current market price of 43 300 KRW, Oscotec Inc is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Oscotec Inc Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
61
vs Industry
6
Median 3Y
120.9
Median 5Y
115.3
Industry
2.6
Forward
28.8
vs History
12
vs Industry
Median 3Y
-30.2
Median 5Y
-36.8
Industry
21.4
Forward
123.2
vs History
3
vs Industry
Median 3Y
-32.9
Median 5Y
-38.2
Industry
16.4
vs History
3
vs Industry
Median 3Y
-33.9
Median 5Y
-39.4
Industry
22.8
vs History
42
vs Industry
6
Median 3Y
9.3
Median 5Y
13.1
Industry
2.2
vs History
63
vs Industry
6
Median 3Y
107
Median 5Y
104.6
Industry
2.9
Forward
26.9
vs History
63
vs Industry
5
Median 3Y
178.2
Median 5Y
161.1
Industry
5.5
vs History
7
vs Industry
Median 3Y
-29.4
Median 5Y
-32.6
Industry
13
Forward
90.1
vs History
7
vs Industry
Median 3Y
-27.5
Median 5Y
-30.8
Industry
16.5
Forward
95.7
vs History
3
vs Industry
Median 3Y
-28.8
Median 5Y
-34
Industry
15.6
vs History
7
vs Industry
Median 3Y
-28
Median 5Y
-33.1
Industry
18.7
vs History
15
vs Industry
5
Median 3Y
24
Median 5Y
24.5
Industry
1.9

Multiples Across Competitors

Competitors Multiples
Oscotec Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
KR
Oscotec Inc
KOSDAQ:039200
1.7T KRW 38.2 389.3 279.6 423.2
US
Eli Lilly and Co
NYSE:LLY
1T USD 17.2 55.5 37.2 39.9
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
498.9B USD 5.4 19.9 16.2 21.1
CH
Roche Holding AG
SIX:ROG
261.4B CHF 4.2 27.7 11.8 13.8
UK
AstraZeneca PLC
LSE:AZN
210.8B GBP 4.9 30.2 108.3 158.6
CH
Novartis AG
SIX:NOVN
210.3B CHF 4.7 18.4 11.7 15.1
US
Merck & Co Inc
NYSE:MRK
264.8B USD 4.1 13.9 9.9 11.7
DK
Novo Nordisk A/S
CSE:NOVO B
1.5T DKK 4.6 14.1 9.9 11.5
IE
Endo International PLC
LSE:0Y5F
213.9B USD 92.2 -73.2 338.7 849.2
US
Pfizer Inc
NYSE:PFE
143.2B USD 2.3 14.6 7.4 10.2
P/E Multiple
Earnings Growth PEG
KR
O
Oscotec Inc
KOSDAQ:039200
Average P/E: 64.8
389.3
508%
0.8
US
Eli Lilly and Co
NYSE:LLY
55.5
54%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
19.9
29%
0.7
CH
Roche Holding AG
SIX:ROG
27.7
29%
1
UK
AstraZeneca PLC
LSE:AZN
30.2
37%
0.8
CH
Novartis AG
SIX:NOVN
18.4
17%
1.1
US
Merck & Co Inc
NYSE:MRK
13.9
15%
0.9
DK
Novo Nordisk A/S
CSE:NOVO B
14.1
3%
4.7
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -73.2 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.6
27%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
KR
O
Oscotec Inc
KOSDAQ:039200
Average EV/EBITDA: 425.2
279.6
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
37.2
34%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16.2
9%
1.8
CH
Roche Holding AG
SIX:ROG
11.8
5%
2.4
UK
AstraZeneca PLC
LSE:AZN
108.3
10%
10.8
CH
Novartis AG
SIX:NOVN
11.7
6%
1.9
US
Merck & Co Inc
NYSE:MRK
9.9
6%
1.6
DK
Novo Nordisk A/S
CSE:NOVO B
9.9
1%
9.9
IE
E
Endo International PLC
LSE:0Y5F
338.7
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.4
0%
N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
KR
O
Oscotec Inc
KOSDAQ:039200
Average EV/EBIT: 1 750.6
423.2
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
39.9
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
21.1
15%
1.4
CH
Roche Holding AG
SIX:ROG
13.8
6%
2.3
UK
AstraZeneca PLC
LSE:AZN
158.6
23%
6.9
CH
Novartis AG
SIX:NOVN
15.1
12%
1.3
US
Merck & Co Inc
NYSE:MRK
11.7
8%
1.5
DK
Novo Nordisk A/S
CSE:NOVO B
11.5
0%
N/A
IE
E
Endo International PLC
LSE:0Y5F
849.2
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.2
7%
1.5